Clinical pleiomorphism in human leishmaniases, with special mention of asymptomatic infection

Clinical Microbiology and Infection

Volumn 17, Issue 10, 2011, Pages 1451-1461

  Banuls A L ^a   Bastien, P ^a,b   Pomares, C ^c,d   Arevalo, J ^e   Fisa, R ^f   Hide, M ^a  

^a University de Montpellier   (France)

^b MONTPELLIER UNIVERSITY HOSPITAL   (France)

^c INSERM   (France)

^d UNIVERSITY HOSPITAL OF NICE   (France)

^e INSTITUTO DE MEDICINA TROPICAL ALEXANDER VON HUMBOLDT   (Peru)

^f UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Asymptomatic carriage; Clinical diversity; Host susceptibility; Immune response; Leishmania; Parasite genetic diversity; Unusual clinical forms

Indexed keywords

ASYMPTOMATIC INFECTION; DISEASE COURSE; DISEASE TRANSMISSION; GENETIC POLYMORPHISM; HUMAN; IMMUNE RESPONSE; LEISHMANIA; LEISHMANIASIS; NONHUMAN; PARASITE VIRULENCE; PATHOGENESIS; PATHOGENICITY; PLEIOTROPY; PRIORITY JOURNAL; REVIEW; SKIN LEISHMANIASIS; SPECIES DIFFERENCE; VISCERAL LEISHMANIASIS;

EID: 80053058479     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2011.03640.x     Document Type: Review

References (153)

1. World Health Organization. Control of the leishmaniases. Report No. 949. WHO, 2011.
2. Desjeux P. Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis 2004; 27: 305-318.
3. Ezra N, Ochoa MT, Craft N. Human immunodeficiency virus and leishmaniasis. J Glob Infect Dis 2010; 2: 248-257.
4. Cruz I, Nieto J, Moreno J, Canavate C, Desjeux P, Alvar J. Leishmania/HIV co-infections in the second decade. Indian J Med Res 2006; 123: 357-388.
5. Bañuls AL, Hide M, Prugnolle F. Leishmania and the leishmaniases: a parasite genetic update and advances in taxonomy, epidemiology and pathogenicity in humans. Adv Parasitol 2007; 64: 1-109.
6. Bastien P. Leishmaniases control: what part for development and what part for research? Clin Microbiol Infect 2011; 17: 1449-1450.
7. den Boer M, Argaw D, Jannin J, Alvar J. Leishmaniasis impact and treatment access. Clin Microbiol Infect 2011; 17: 1471-1477.
8. Ameen M. Cutaneous leishmaniasis: advances in disease pathogenesis, diagnostics and therapeutics. Clin Exp Dermatol 2010; 35: 699-705.
9. Dedet J, Pratlong F. Leishmaniasis. In: Cook G, Zumla A, eds. Manson's tropical diseases, 22nd edn. Philadelphia, PA: Saunders, 2009; 1341-1365.
10. Dedet JP, Pratlong F, Lanotte G, Ravel C. Cutaneous leishmaniasis. The parasite. Clin Dermatol 1999; 17: 261-268.
11. Ponce C, Ponce E, Morrison A et al. Leishmania donovani chagasi: new clinical variant of cutaneous leishmaniasis in Honduras. Lancet 1991; 337: 67-70.
12. Karunaweera ND. Leishmania donovani causing cutaneous leishmaniasis in Sri Lanka: a wolf in sheep's clothing? Trends Parasitol 2009; 25: 458-463.
13. Pratlong F, Bastien P, Perello R, Lami P, Dedet JP. Human cutaneous leishmaniasis caused by Leishmania donovani sensu stricto in Yemen. Trans R Soc Trop Med Hyg 1995; 89: 398-399.
14. Akilov OE, Khachemoune A, Hasan T. Clinical manifestations and classification of Old World cutaneous leishmaniasis. Int J Dermatol 2007; 46: 132-142.
15. Hepburn NC. Cutaneous leishmaniasis: an overview. J Postgrad Med 2003; 49: 50-54.
16. Hide M, Bucheton B, Kamhawi S et al. Understanding human leishmaniasis: the need for an integrated approach. In: Tibayrenc M, ed. Encyclopedic guide to infectious disease research: modern methodologies. Hoboken: Wiley, 2007; 87-123.
17. Goto H, Lindoso JA. Current diagnosis and treatment of cutaneous and mucocutaneous leishmaniasis. Expert Rev Anti Infect Ther 2010; 8: 419-433.
18. Karincaoglu Y, Esrefoglu M, Ozcan H. Atypical clinical form of cutaneous leishmaniasis: erysipeloid form. Int J Dermatol 2004; 43: 827-829.
19. Iftikhar N, Bari I, Ejaz A. Rare variants of cutaneous leishmaniasis: whitlow, paronychia, and sporotrichoid. Int J Dermatol 2003; 42: 807-809.
20. Raja KM, Khan AA, Hameed A, Rahman SB. Unusual clinical variants of cutaneous leishmaniasis in Pakistan. Br J Dermatol 1998; 139: 111-113.
21. Bari AU, Rahman SB. Many faces of cutaneous leishmaniasis. Indian J Dermatol Venereol Leprol 2008; 74: 23-27.
22. Bari A, Bari A, Ejaz A. Fissure leishmaniasis: a new variant of cutaneous leishmaniasis. Dermatol Online J 2009; 15: 13.
23. Guimaraes LH, Machado PR, Lago EL et al. Atypical manifestations of tegumentary leishmaniasis in a transmission area of Leishmania braziliensis in the state of Bahia, Brazil. Trans R Soc Trop Med Hyg 2009; 103: 712-715.
24. Padovese V, Terranova M, Toma L, Barnabas GA, Morrone A. Cutaneous and mucocutaneous leishmaniasis in Tigray, northern Ethiopia: clinical aspects and therapeutic concerns. Trans R Soc Trop Med Hyg 2009; 103: 707-711.
25. Kubba R, el-Hassan AM, Al-Gindan Y, Omer AH, Kutty MK, Saeed MB. Dissemination in cutaneous leishmaniasis. I. Subcutaneous nodules. Int J Dermatol 1987; 26: 300-304.
26. Lindoso JA, Barbosa RN, Posada-Vergara MP et al. Unusual manifestations of tegumentary leishmaniasis in AIDS patients from the New World. Br J Dermatol 2009; 160: 311-318.
27. Cabello I, Caraballo A, Millan Y. Leishmaniasis in the genital area. Rev Inst Med Trop Sao Paulo 2002; 44: 105-107.
28. Alvar J, Aparicio P, Aseffa A et al. The relationship between leishmaniasis and AIDS: the second 10 years. Clin Microbiol Rev 2008; 21: 334-359.
29. White SW, Hendricks LD. American cutaneous leishmaniasis. Int J Dermatol 1982; 21: 86-88.
30. Colebunders R, Depraetere K, Verstraeten T et al. Unusual cutaneous lesions in two patients with visceral leishmaniasis and HIV infection. J Am Acad Dermatol 1999; 41: 847-850.
31. Shani-Adir A, Kamil S, Rozenman D et al. Leishmania tropica in northern Israel: a clinical overview of an emerging focus. J Am Acad Dermatol 2005; 53: 810-815.
32. Faye B, Bañuls AL, Bucheton B et al. Canine visceral leishmaniasis caused by Leishmania infantum in Senegal: risk of emergence in humans? Microbes Infect 2010; 12: 1219-1225.
33. Samaranayake TN, Dissanayake VH, Fernando SD. Clinical manifestations of cutaneous leishmaniasis in Sri Lanka-possible evidence for genetic susceptibility among the Sinhalese. Ann Trop Med Parasitol 2008; 102: 383-390.
34. Calvopina M, Uezato H, Gomez EA, Korenaga M, Nonaka S, Hashiguchi Y. Leishmaniasis recidiva cutis due to Leishmania (Viannia) panamensis in subtropical Ecuador: isoenzymatic characterization. Int J Dermatol 2006; 45: 116-120.
35. Kubba R, al-Gindan Y, el-Hassan AM, Omer AH, Kutty MK, Saeed MB. Dissemination in cutaneous leishmaniasis. II. Satellite papules and subcutaneous induration. Int J Dermatol 1988; 27: 702-706.
36. Grevelink SA, Lerner EA. Leishmaniasis. J Am Acad Dermatol 1996; 34: 257-272.
37. Murray HW, Berman JD, Davies CR, Saravia NG. Advances in leishmaniasis. Lancet 2005; 366: 1561-1577.
38. Sinha S, Fernandez G, Kapila R, Lambert WC, Schwartz RA. Diffuse cutaneous leishmaniasis associated with the immune reconstitution inflammatory syndrome. Int J Dermatol 2008; 47: 1263-1270.
39. Couppie P, Clyti E, Sobesky M et al. Comparative study of cutaneous leishmaniasis in human immunodeficiency virus (HIV)-infected patients and non-HIV-infected patients in French Guiana. Br J Dermatol 2004; 151: 1165-1171.
40. Rosatelli JB, Souza CS, Soares FA, Foss NT, Roselino AM. Generalized cutaneous leishmaniasis in acquired immunodeficiency syndrome. J Eur Acad Dermatol Venereol 1998; 10: 229-232.
41. Ganguly S, Das NK, Barbhuiya JN, Chatterjee M. Post-kala-azar dermal leishmaniasis-an overview. Int J Dermatol 2010; 49: 921-931.
42. Veraldi S, Bottini S, Curro N, Gianotti R. Leishmaniasis of the eyelid mimicking an infundibular cyst and review of the literature on ocular leishmaniasis. Int J Infect Dis 2010; 14 (suppl 3): e230-e232.
43. Zeegelaar JE, Faber WR. Imported tropical infectious ulcers in travelers. Am J Clin Dermatol 2008; 9: 219-232.
44. Tojal da Silva AC, Cupolillo E, Volpini AC, Almeida R, Romero GA. Species diversity causing human cutaneous leishmaniasis in Rio Branco, state of Acre, Brazil. Trop Med Int Health 2006; 11: 1388-1398.
45. Guerra JA, Prestes SR, Silveira H et al. Mucosal leishmaniasis caused by Leishmania (Viannia) braziliensis and Leishmania (Viannia) guyanensis in the Brazilian Amazon. PLoS Negl Trop Dis 2011; 5: e980.
46. Barral A, Pedral-Sampaio D, Grimaldi Junior G et al. Leishmaniasis in Bahia, Brazil: evidence that Leishmania amazonensis produces a wide spectrum of clinical disease. Am J Trop Med Hyg 1991; 44: 536-546.
47. Casero R, Laconte L, Fraenza L, Iglesias N, Quinteros Greco C, Villablanca M. Recidivant laryngeal leishmaniasis: an unusual case in an immunocompetent patient treated with corticosteroids. Rev Argent Microbiol 2010; 42: 118-121.
48. Lessa MM, Lessa HA, Castro TW et al. Mucosal leishmaniasis: epidemiological and clinical aspects. Braz J Otorhinolaryngol 2007; 73: 843-847.
49. Motta AC, Arruda D, Souza CS, Foss NT. Disseminated mucocutaneous leishmaniasis resulting from chronic use of corticosteroid. Int J Dermatol 2003; 42: 703-706.
50. Motta AC, Lopes MA, Ito FA, Carlos-Bregni R, de Almeida OP, Roselino AM. Oral leishmaniasis: a clinicopathological study of 11 cases. Oral Dis 2007; 13: 335-340.
51. Faucher B, Pomares C, Fourcade S et al. Mucosal Leishmania infantum leishmaniasis: specific pattern in a multicentre survey and historical cases. J Infect 2011; 63: 76-82.
52. John TJ, Dandona L, Sharma VP, Kakkar M. Continuing challenge of infectious diseases in India. Lancet 2011; 377: 252-269.
53. Seaman J, Mercer AJ, Sondorp E. The epidemic of visceral leishmaniasis in western Upper Nile, southern Sudan: course and impact from 1984 to 1994. Int J Epidemiol 1996; 25: 862-871.
54. Nasereddin A, Baneth G, Schonian G, Kanaan M, Jaffe CL. Molecular fingerprinting of Leishmania infantum strains following an outbreak of visceral leishmaniasis in central Israel. J Clin Microbiol 2005; 43: 6054-6059.
55. Postigo JA. Leishmaniasis in the World Health Organization Eastern Mediterranean Region. Int J Antimicrob Agents 2010; 36 (suppl 1): S62-S65.
56. Herwaldt BL. Leishmaniasis. Lancet 1999; 354: 1191-1199.
57. Magill AJ, Grogl M, Gasser RA Jr, Sun W, Oster CN. Visceral infection caused by Leishmania tropica in veterans of Operation Desert Storm. N Engl J Med 1993; 328: 1383-1387.
58. Hernandez DE, Oliver M, Martinez C, Planas G. Visceral leishmaniasis with cutaneous and rectal dissemination due to Leishmania braziliensis in acquired immunodeficiency syndrome (AIDS). Int J Dermatol 1995; 34: 114-115.
59. Jeziorski E, Blanchet C, Ludwig C et al. Pseudotumoral-like recurrence of visceral leishmaniasis in a seven-year-old girl. Arch Pediatr 2009; 16 (suppl 2): S129-S131.
60. Alvar J, Canavate C, Gutierrez-Solar B et al. Leishmania and human immunodeficiency virus coinfection: the first 10 years. Clin Microbiol Rev 1997; 10: 298-319.
61. Pasquau F, Ena J, Sanchez R et al. Leishmaniasis as an opportunistic infection in HIV-infected patients: determinants of relapse and mortality in a collaborative study of 228 episodes in a Mediterreanean region. Eur J Clin Microbiol Infect Dis 2005; 24: 411-418.
62. Alvar J, Croft S, Olliaro P. Chemotherapy in the treatment and control of leishmaniasis. Adv Parasitol 2006; 61: 223-274.
63. Bourgeois N, Lachaud L, Reynes J, Rouanet I, Mahamat A, Bastien P. Long-term monitoring of visceral leishmaniasis in patients with AIDS: relapse risk factors, value of polymerase chain reaction, and potential impact on secondary prophylaxis. J Acquir Immune Defic Syndr 2008; 48: 13-19.
64. Bourgeois N, Bastien P, Reynes J, Makinson A, Rouanet I, Lachaud L. 'Active chronic visceral leishmaniasis' in HIV-1-infected patients demonstrated by biological and clinical long-term follow-up of 10 patients. HIV Med 2010; 11: 670-673.
65. Lachaud L, Chabbert E, Dubessay P et al. Value of two PCR methods for the diagnosis of canine visceral leishmaniasis and the detection of asymptomatic carriers. Parasitology 2002; 125: 197-207.
66. Martinez P, de la Vega E, Laguna F et al. Diagnosis of visceral leishmaniasis in HIV-infected individuals using peripheral blood smears. AIDS 1993; 7: 227-230.
67. Fillola G, Corberand JX, Laharrague PF, Levenes H, Massip P, Recco P. Peripheral intramonocytic leishmanias in an AIDS patient. J Clin Microbiol 1992; 30: 3284-3285.
68. Molina R, Lopez-Velez R, Gutierrez-Solar B, Jimenez I, Alvar J. Isolation of Leishmania infantum from the blood of a patient with AIDS using sandflies. Trans R Soc Trop Med Hyg 1992; 86: 516.
69. Mathis A, Deplazes P. PCR and in vitro cultivation for detection of Leishmania spp. in diagnostic samples from humans and dogs. J Clin Microbiol 1995; 33: 1145-1149.
70. Nicolas L, Sidjanski S, Colle JH, Milon G. Leishmania major reaches distant cutaneous sites where it persists transiently while persisting durably in the primary dermal site and its draining lymph node: a study with laboratory mice. Infect Immun 2000; 68: 6561-6566.
71. Gradoni L, Gramiccia M. Leishmania infantum tropism: strain genotype or host immune status? Parasitol Today 1994; 10: 264-267.
72. Callahan HL, Portal IF, Bensinger SJ, Grogl M. Leishmania spp: temperature sensitivity of promastigotes in vitro as a model for tropism in vivo. Exp Parasitol 1996; 84: 400-409.
73. Zhang WW, Matlashewski G. Screening Leishmania donovani-specific genes required for visceral infection. Mol Microbiol 2010; 77: 505-517.
74. Mougneau E, Bihl F, Glaichenhaus N. Cell biology and immunology of Leishmania. Immunol Rev 2011; 240: 286-296.
75. Nylen S, Gautam S. Immunological perspectives of leishmaniasis. J Glob Infect Dis 2010; 2: 135-146.
76. Frank SA, Schmid-Hempel P. Mechanisms of pathogenesis and the evolution of parasite virulence. J Evol Biol 2008; 21: 396-404.
77. Olivier M, Gregory DJ, Forget G. Subversion mechanisms by which Leishmania parasites can escape the host immune response: a signaling point of view. Clin Microbiol Rev 2005; 18: 293-305.
78. Silva VM, Larangeira DF, Oliveira PR et al. Enhancement of experimental cutaneous leishmaniasis by Leishmania molecules is dependent on interleukin-4, serine protease/esterase activity, and parasite and host genetic backgrounds. Infect Immun 2011; 79: 1236-1243.
79. El-Safi S, Kheir MM, Bucheton B et al. Genes and environment in susceptibility to visceral leishmaniasis. C R Biol 2006; 329: 863-870.
80. Havelkova H, Badalova J, Svobodova M et al. Genetics of susceptibility to leishmaniasis in mice: four novel loci and functional heterogeneity of gene effects. Genes Immun 2006; 7: 220-233.
81. Ramasawmy R, Menezes E, Magalhaes A et al. The -2518bp promoter polymorphism at CCL2/MCP1 influences susceptibility to mucosal but not localized cutaneous leishmaniasis in Brazil. Infect Genet Evol 2010; 10: 607-613.
82. Frade AF, Oliveira LC, Costa DL et al. TGFB1 and IL8 gene polymorphisms and susceptibility to visceral leishmaniasis. Infect Genet Evol 2011; 11: 912-916.
83. Ajdary S, Ghamilouie MM, Alimohammadian MH, Riazi-Rad F, Pakzad SR. Toll-like receptor 4 polymorphisms predispose to cutaneous leishmaniasis. Microbes Infect 2011; 13: 226-231.
84. Castellucci L, Menezes E, Oliveira J et al. IL6-174G/C promoter polymorphism influences susceptibility to mucosal but not localized cutaneous leishmaniasis in Brazil. J Infect Dis 2006; 194: 519-527.
85. Sakthianandeswaren A, Foote SJ, Handman E. The role of host genetics in leishmaniasis. Trends Parasitol 2009; 25: 383-391.
86. Bucheton B, Kheir MM, El-Safi SH et al. The interplay between environmental and host factors during an outbreak of visceral leishmaniasis in eastern Sudan. Microbes Infect 2002; 4: 1449-1457.
87. Bucheton B, Abel L, El-Safi S et al. A major susceptibility locus on chromosome 22q12 plays a critical role in the control of kala-azar. Am J Hum Genet 2003; 73: 1052-1060.
88. Bucheton B, Abel L, Kheir MM et al. Genetic control of visceral leishmaniasis in a Sudanese population: candidate gene testing indicates a linkage to the NRAMP1 region. Genes Immun 2003; 4: 104-109.
89. Alimohammadian MH, Darabi H, Ajdary S, Khaze V, Torkabadi E. Genotypically distinct strains of Leishmania major display diverse clinical and immunological patterns in BALB/c mice. Infect Genet Evol 2010; 10: 969-975.
90. Swenerton RK, Zhang S, Sajid M et al. The oligopeptidase B of Leishmania regulates parasite enolase and immune evasion. J Biol Chem 2011; 286: 429-440.
91. Murray AS, Lynn MA, McMaster WR. The Leishmania mexicana A600 genes are functionally required for amastigote replication. Mol Biochem Parasitol 2010; 172: 80-89.
92. Hide M, Bañuls AL. Polymorphisms of cpb multicopy genes in the Leishmania (Leishmania) donovani complex. Trans R Soc Trop Med Hyg 2008; 102: 105-106.
93. Hide M, Bras-Goncalves R, Bañuls AL. Specific cpb copies within the Leishmania donovani complex: evolutionary interpretations and potential clinical implications in humans. Parasitology 2007; 134: 379-389.
94. Dujardin JC, Bañuls AL, Victoir K et al. From population to genome: ecogenetics of Leishmania (Viannia) braziliensis and L. (V.) peruviana. Ann Trop Med Parasitol 1995; 89 (suppl 1): 45-53.
95. Peacock CS, Seeger K, Harris D et al. Comparative genomic analysis of three Leishmania species that cause diverse human disease. Nat Genet 2007; 39: 839-847.
96. Smith DF, Peacock CS, Cruz AK. Comparative genomics: from genotype to disease phenotype in the leishmaniases. Int J Parasitol 2007; 37: 1173-1186.
97. Lynn MA, McMaster WR. Leishmania: conserved evolution-diverse diseases. Trends Parasitol 2008; 24: 103-105.
98. Clayton CE. Life without transcriptional control? From fly to man and back again. EMBO J 2002; 21: 1881-1888.
99. Hitchcock RA, Thomas S, Campbell DA, Sturm NR. The promoter and transcribed regions of the Leishmania tarentolae spliced leader RNA gene array are devoid of nucleosomes. BMC Microbiol 2007; 7: 44.
100. Bates PA. Transmission of Leishmania metacyclic promastigotes by phlebotomine sand flies. Int J Parasitol 2007; 37: 1097-1106.
101. Kamhawi S. The biological and immunomodulatory properties of sand fly saliva and its role in the establishment of Leishmania infections. Microbes Infect 2000; 2: 1765-1773.
102. Rohousova I, Volf P. Sand fly saliva: effects on host immune response and Leishmania transmission. Folia Parasitol (Praha) 2006; 53: 161-171.
103. Rogers ME, Corware K, Muller I, Bates PA. Leishmania infantum proteophosphoglycans regurgitated by the bite of its natural sand fly vector, Lutzomyia longipalpis, promote parasite establishment in mouse skin and skin-distant tissues. Microbes Infect 2010; 12: 875-879.
104. Ives A, Ronet C, Prevel F et al. Leishmania RNA virus controls the severity of mucocutaneous leishmaniasis. Science 2011; 331: 775-778.
105. de La Llave E, Lecoeur H, Besse A, Milon G, Prina E, Lang T. A combined luciferase imaging and reverse transcription polymerase chain reaction assay for the study of Leishmania amastigote burden and correlated mouse tissue transcript fluctuations. Cell Microbiol 2011; 13: 81-91.
106. Prina E, Roux E, Mattei D, Milon G. Leishmania DNA is rapidly degraded following parasite death: an analysis by microscopy and real-time PCR. Microbes Infect 2007; 9: 1307-1315.
107. Oliva G, Scalone A, Foglia Manzillo V et al. Incidence and time course of Leishmania infantum infections examined by parasitological, serologic, and nested-PCR techniques in a cohort of naive dogs exposed to three consecutive transmission seasons. J Clin Microbiol 2006; 44: 1318-1322.
108. Martinez V, Quilez J, Sanchez A, Roura X, Francino O, Altet L. Canine leishmaniasis: the key points for qPCR result interpretation. Parasit Vectors 2011; 4: 57.
109. Monecke S, Luedicke C, Slickers P, Ehricht R. Molecular epidemiology of Staphylococcus aureus in asymptomatic carriers. Eur J Clin Microbiol Infect Dis 2009; 28: 1159-1165.
110. Sitki-Green D, Covington M, Raab-Traub N. Compartmentalization and transmission of multiple Epstein-Barr virus strains in asymptomatic carriers. J Virol 2003; 77: 1840-1847.
111. Singh BB, Sharma R, Sharma JK, Juyal PD. Parasitic zoonoses in India: an overview. Rev Sci Tech 2011; 29: 629-637.
112. Harris I, Sharrock WW, Bain LM et al. A large proportion of asymptomatic Plasmodium infections with low and sub-microscopic parasite densities in the low transmission setting of Temotu Province, Solomon Islands: challenges for malaria diagnostics in an elimination setting. Malar J 2010; 9: 254.
113. Costa CH, Stewart JM, Gomes RB et al. Asymptomatic human carriers of Leishmania chagasi. Am J Trop Med Hyg 2002; 66: 334-337.
114. Courtenay O, Quinnell RJ, Garcez LM, Shaw JJ, Dye C. Infectiousness in a cohort of Brazilian dogs: why culling fails to control visceral leishmaniasis in areas of high transmission. J Infect Dis 2002; 186: 1314-1320.
115. Vieira J, Coelho G. Leishmaniose visceral ou calazar: aspectos epidemiológicos e de controle. Rev Soc Bras Med Trop 1998; 31(suppl II): 85-92.
116. Dietze R, Barros GB, Teixeira L et al. Effect of eliminating seropositive canines on the transmission of visceral leishmaniasis in Brazil. Clin Infect Dis 1997; 25: 1240-1242.
117. Molina R, Amela C, Nieto J et al. Infectivity of dogs naturally infected with Leishmania infantum to colonized Phlebotomus perniciosus. Trans R Soc Trop Med Hyg 1994; 88: 491-493.
118. Moshfe A, Mohebali M, Edrissian G et al. Canine visceral leishmaniasis: asymptomatic infected dogs as a source of L. infantum infection. Acta Trop 2009; 112: 101-105.
119. Lima LV, Carneiro LA, Campos MB et al. Canine visceral leishmaniasis due to Leishmania (L.) infantum chagasi in Amazonian Brazil: comparison of the parasite density from the skin, lymph node and visceral tissues between symptomatic and asymptomatic, seropositive dogs. Rev Inst Med Trop Sao Paulo 2010; 52: 259-266.
120. Lainson R, Shaw JJ. Evolution, classification and geographical distribution. In: Peters W, Killick-Kendrick R, eds. The leishmaniases in biology and medicine. London: Academic Press, 1987; 1-120.
121. Biglino A, Bolla C, Concialdi E, Trisciuoglio A, Romano A, Ferroglio E. Asymptomatic Leishmania infantum infection in an area of northwestern Italy (Piedmont region) where such infections are traditionally nonendemic. J Clin Microbiol 2010; 48: 131-136.
122. Le Fichoux Y, Quaranta JF, Aufeuvre JP et al. Occurrence of Leishmania infantum parasitemia in asymptomatic blood donors living in an area of endemicity in southern France. J Clin Microbiol 1999; 37: 1953-1957.
123. Riera C, Fisa R, Udina M, Gallego M, Portus M. Detection of Leishmania infantum cryptic infection in asymptomatic blood donors living in an endemic area (Eivissa, Balearic Islands, Spain) by different diagnostic methods. Trans R Soc Trop Med Hyg 2004; 98: 102-110.
124. Alborzi A, Pourabbas B, Shahian F, Mardaneh J, Pouladfar GR, Ziyaeyan M. Detection of Leishmania infantum kinetoplast DNA in the whole blood of asymptomatic individuals by PCR-ELISA and comparison with other infection markers in endemic areas, southern Iran. Am J Trop Med Hyg 2008; 79: 839-842.
125. Mary C, Faraut F, Drogoul MP et al. Reference values for Leishmania infantum parasitemia in different clinical presentations: quantitative polymerase chain reaction for therapeutic monitoring and patient follow-up. Am J Trop Med Hyg 2006; 75: 858-863.
126. Garcia-Garcia JA, Martin-Sanchez J, Gallego M et al. Use of noninvasive markers to detect Leishmania infection in asymptomatic human immunodeficiency virus-infected patients. J Clin Microbiol 2006; 44: 4455-4458.
127. Scarlata F, Vitale F, Saporito L et al. Asymptomatic Leishmania infantum/chagasi infection in blood donors of western Sicily. Trans R Soc Trop Med Hyg 2008; 102: 394-396.
128. Colomba C, Saporito L, Vitale F et al. Cryptic Leishmania infantum infection in Italian HIV infected patients. BMC Infect Dis 2009; 9: 199.
129. Singh SP, Picado A, Boelaert M et al. The epidemiology of Leishmania donovani infection in high transmission foci in India. Trop Med Int Health 2010; 15 (suppl 2): 12-20.
130. Reale S, Maxia L, Vitale F, Glorioso NS, Caracappa S, Vesco G. Detection of Leishmania infantum in dogs by PCR with lymph node aspirates and blood. J Clin Microbiol 1999; 37: 2931-2935.
131. Solano-Gallego L, Morell P, Arboix M, Alberola J, Ferrer L. Prevalence of Leishmania infantum infection in dogs living in an area of canine leishmaniasis endemicity using PCR on several tissues and serology. J Clin Microbiol 2001; 39: 560-563.
132. Berrahal F, Mary C, Roze M et al. Canine leishmaniasis: identification of asymptomatic carriers by polymerase chain reaction and immunoblotting. Am J Trop Med Hyg 1996; 55: 273-277.
133. Quinnell RJ, Courtenay O, Davidson S et al. Detection of Leishmania infantum by PCR, serology and cellular immune response in a cohort study of Brazilian dogs. Parasitology 2001; 122: 253-261.
134. Aoun O, Mary C, Roqueplo C et al. Canine leishmaniasis in south-east of France: screening of Leishmania infantum antibodies (western blotting, ELISA) and parasitaemia levels by PCR quantification. Vet Parasitol 2009; 166: 27-31.
135. Moreno EC, Goncalves AV, Chaves AV et al. Inaccuracy of enzyme-linked immunosorbent assay using soluble and recombinant antigens to detect asymptomatic infection by Leishmania infantum. PLoS Negl Trop Dis 2009; 3: e536.
136. Silveira FT, Lainson R, Pereira EA et al. A longitudinal study on the transmission dynamics of human Leishmania (Leishmania) infantum chagasi infection in Amazonian Brazil, with special reference to its prevalence and incidence. Parasitol Res 2009; 104: 559-567.
137. Lachaud L, Marchergui-Hammami S, Chabbert E, Dereure J, Dedet JP, Bastien P. Comparison of six PCR methods using peripheral blood for detection of canine visceral leishmaniasis. J Clin Microbiol 2002; 40: 210-215.
138. Cardo LJ. Leishmania: risk to the blood supply. Transfusion 2006; 46: 1641-1645.
139. Dey A, Singh S. Transfusion transmitted leishmaniasis: a case report and review of literature. Indian J Med Microbiol 2006; 24: 165-170.
140. Cohen C, Corazza F, De Mol P, Brasseur D. Leishmaniasis acquired in Belgium. Lancet 1991; 338: 128.
141. Singh S, Chaudhry VP, Wali JP. Transfusion-transmitted kala-azar in India. Transfusion 1996; 36: 848-849.
142. de Freitas E, Melo MN, da Costa-Val AP, Michalick MS. Transmission of Leishmania infantum via blood transfusion in dogs: potential for infection and importance of clinical factors. Vet Parasitol 2006; 137: 159-167.
143. Brouard C, De Valk H, Pilloneln J. Quantitative estimation of the risk of blood donation infection by infectious agents. Paris: French Institute for Public Health Surveillance (InVS), 2007.
144. Riera C, Fisa R, Lopez-Chejade P et al. Asymptomatic infection by Leishmania infantum in blood donors from the Balearic Islands (Spain). Transfusion 2008; 48: 1383-1389.
145. Cardo LJ, Rentas FJ, Ketchum L et al. Pathogen inactivation of Leishmania donovani infantum in plasma and platelet concentrates using riboflavin and ultraviolet light. Vox Sang 2006; 90: 85-91.
146. Oliveira RA, Silva LS, Carvalho VP et al. Visceral leishmaniasis after renal transplantation: report of 4 cases in northeastern Brazil. Transpl Infect Dis 2008; 10: 364-368.
147. Weisser M, Khanlari B, Terracciano L et al. Visceral leishmaniasis: a threat to immunocompromised patients in non-endemic areas? Clin Microbiol Infect 2007; 13: 751-753.
148. Pittalis S, Nicastri E, Spinazzola F et al. Leishmania infantum leishmaniasis in corticosteroid-treated patients. BMC Infect Dis 2006; 6: 177.
149. Marty P, Izri A, Ozon C et al. A century of leishmaniasis in Alpes-Maritimes, France. Ann Trop Med Parasitol 2007; 101: 563-574.
150. Minodier P, Piarroux R, Garnier JM, Unal D, Perrimond H, Dumon H. Pediatric visceral leishmaniasis in southern France. Pediatr Infect Dis J 1998; 17: 701-704.
151. Khalil EA, Zijlstra EE, Kager PA, El Hassan AM. Epidemiology and clinical manifestations of Leishmania donovani infection in two villages in an endemic area in eastern Sudan. Trop Med Int Health 2002; 7: 35-44.
152. El-Safi S, Bucheton B, Kheir MM et al. Epidemiology of visceral leishmaniasis in Atbara River area, eastern Sudan: the outbreak of Barbar El Fugara village (1996-1997). Microbes Infect 2002; 4: 1439-1447.
153. Ibrahim ME, Lambson B, Yousif AO et al. Kala-azar in a high transmission focus: an ethnic and geographic dimension. Am J Trop Med Hyg 1999; 61: 941-944.